Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
-4.85%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$346M
Cap. Flow %
-2.17%
Top 10 Hldgs %
35.77%
Holding
1,458
New
33
Increased
733
Reduced
273
Closed
36

Sector Composition

1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RUBY
1201
DELISTED
Rubius Therapeutics, Inc
RUBY
$2K ﹤0.01%
307
IMGO
1202
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$2K ﹤0.01%
98
FMTX
1203
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2K ﹤0.01%
162
ENDP
1204
DELISTED
Endo International plc
ENDP
$2K ﹤0.01%
800
IPSC icon
1205
Century Therapeutics
IPSC
$43.4M
$2K ﹤0.01%
159
JANX icon
1206
Janux Therapeutics
JANX
$1.43B
$2K ﹤0.01%
121
KZR icon
1207
Kezar Life Sciences
KZR
$29.4M
$2K ﹤0.01%
15
+6
+67% +$800
MCRB icon
1208
Seres Therapeutics
MCRB
$163M
$2K ﹤0.01%
16
MGNX icon
1209
MacroGenics
MGNX
$109M
$2K ﹤0.01%
209
MGTX icon
1210
MeiraGTx Holdings
MGTX
$615M
$2K ﹤0.01%
130
MIRM icon
1211
Mirum Pharmaceuticals
MIRM
$3.9B
$2K ﹤0.01%
89
MXCT icon
1212
MaxCyte
MXCT
$151M
$2K ﹤0.01%
293
NRIX icon
1213
Nurix Therapeutics
NRIX
$703M
$2K ﹤0.01%
152
NUVL icon
1214
Nuvalent
NUVL
$5.68B
$2K ﹤0.01%
125
QSI icon
1215
Quantum-Si Incorporated
QSI
$233M
$2K ﹤0.01%
343
ABSI icon
1216
Absci
ABSI
$380M
$2K ﹤0.01%
270
ACET icon
1217
Adicet Bio
ACET
$66.9M
$2K ﹤0.01%
117
+58
+98% +$991
AFMD
1218
DELISTED
Affimed
AFMD
$2K ﹤0.01%
41
AKRO icon
1219
Akero Therapeutics
AKRO
$3.57B
$2K ﹤0.01%
119
ALXO icon
1220
ALX Oncology
ALXO
$58.4M
$2K ﹤0.01%
138
ATAI icon
1221
ATAI Life Sciences
ATAI
$1.05B
$2K ﹤0.01%
468
AVIR icon
1222
Atea Pharmaceuticals
AVIR
$251M
$2K ﹤0.01%
242
BVS icon
1223
Bioventus
BVS
$486M
$2K ﹤0.01%
173
COLL icon
1224
Collegium Pharmaceutical
COLL
$1.2B
$2K ﹤0.01%
76
CRBU icon
1225
Caribou Biosciences
CRBU
$171M
$2K ﹤0.01%
176